Correlates of PDE5i use among subjects with erectile dysfunction in two population-based surveys
- PMID: 21834873
- PMCID: PMC3548233
- DOI: 10.1111/j.1743-6109.2011.02423.x
Correlates of PDE5i use among subjects with erectile dysfunction in two population-based surveys
Abstract
Introduction: Erectile dysfunction (ED) is thought to affect some 150 million men worldwide, but many men with ED symptoms do not seek treatment. Existing surveys suggest that men with severe ED and who report support from their partners are more likely to receive treatment than were others. Less is known, however, concerning the influence of sociomedical factors such as income and body composition on receipt of treatment.
Aim: The aim of this study was to determine the importance of socioeconomic status, comorbidities, and body composition on receipt of treatment for ED symptoms.
Methods: We used data on 638 men enrolled in the Boston Area Community Health (BACH) survey reporting ED symptoms and/or treatment for ED as evidenced by phosphodiesterase type 5 inhibitor (PDE5i) use. Logistic regression was employed to assess the relative strength of association between receipt of treatment and socioeconomic factors, body mass index, and medical factors. A replication of these results was then provided via a parallel model using the 2004 follow-up of the Men's Attitudes to Life Events and Sexuality (MALES).
Main outcome measure: In BACH, ED was deemed present if a subject scored 16 points or fewer on the five-item International Index of Erectile Function or reported PDE5i use. In MALES, presence of ED was indicated by use of a validated single question querying ED severity.
Results: Controlling for age, body composition and other factors, increased household income, availability of a sexual partner, and provider diagnosis of high blood pressure were positively associated with treatment seeking via the use of PDE5i therapy in BACH. Results on data available in MALES produced similar results for household income and partner availability.
Conclusion: These data provide evidence that financial disadvantage may present a barrier to treatment of ED, an increasingly important sentinel marker of the cardiovascular and overall health among aging men.
© 2011 International Society for Sexual Medicine.
Comment in
-
Re: correlates of PDE5i use among subjects with erectile dysfunction in two population-based surveys.J Urol. 2012 May;187(5):1788-9. doi: 10.1016/j.juro.2012.01.101. Epub 2012 Mar 15. J Urol. 2012. PMID: 22494746 No abstract available.
Similar articles
-
An Evaluation of a Clinical Care Pathway for the Management of Men With Nonorganic Erectile Dysfunction.J Sex Med. 2019 Oct;16(10):1541-1546. doi: 10.1016/j.jsxm.2019.07.013. Epub 2019 Aug 20. J Sex Med. 2019. PMID: 31444103 Free PMC article.
-
The multinational Men's Attitudes to Life Events and Sexuality (MALES) Study Phase II: understanding PDE5 inhibitor treatment seeking patterns, among men with erectile dysfunction.J Sex Med. 2004 Sep;1(2):150-60. doi: 10.1111/j.1743-6109.2004.04023.x. J Sex Med. 2004. PMID: 16422969 Clinical Trial.
-
Erectile dysfunction (ED) is a shared sexual concern of couples II: association of female partner characteristics with male partner ED treatment seeking and phosphodiesterase type 5 inhibitor utilization.J Sex Med. 2009 Nov;6(11):3111-24. doi: 10.1111/j.1743-6109.2009.01432.x. Epub 2009 Aug 11. J Sex Med. 2009. PMID: 19674250
-
Systematic Review of Oral Combination Therapy for Erectile Dysfunction When Phosphodiesterase Type 5 Inhibitor Monotherapy Fails.Sex Med Rev. 2019 Jul;7(3):430-441. doi: 10.1016/j.sxmr.2018.11.007. Epub 2019 Jan 30. Sex Med Rev. 2019. PMID: 30711478
-
Erectile dysfunction diagnosis and treatment as a means to improve medication adherence and optimize comorbidity management.J Sex Med. 2013 Feb;10(2):551-61. doi: 10.1111/j.1743-6109.2012.02998.x. Epub 2012 Nov 15. J Sex Med. 2013. PMID: 23153075 Review.
Cited by
-
The dangers of sexual enhancement supplements and counterfeit drugs to "treat" erectile dysfunction.Transl Androl Urol. 2017 Feb;6(1):12-19. doi: 10.21037/tau.2016.10.04. Transl Androl Urol. 2017. PMID: 28217446 Free PMC article. Review.
-
Long-term effects of phosphodiesterase-5 inhibitors on cardiovascular outcomes and death: a systematic review and meta-analysis.Eur Heart J Cardiovasc Pharmacother. 2024 Aug 14;10(5):403-412. doi: 10.1093/ehjcvp/pvae029. Eur Heart J Cardiovasc Pharmacother. 2024. PMID: 38777751 Free PMC article.
-
Sociodemographic patterns in pharmacy dispensing of medications for erectile dysfunction in Sweden.Eur J Clin Pharmacol. 2018 Feb;74(2):209-218. doi: 10.1007/s00228-017-2361-9. Epub 2017 Nov 3. Eur J Clin Pharmacol. 2018. PMID: 29101427 Free PMC article.
-
Predicting erectile dysfunction in sexually active patients seeking prostate health screening: proposal for a multivariable risk stratification.Int J Impot Res. 2015 Nov-Dec;27(6):201-5. doi: 10.1038/ijir.2015.15. Epub 2015 Jul 30. Int J Impot Res. 2015. PMID: 26224573
-
Efficacy of Chinese Herbal Medicine Formula in the Treatment of Mild to Moderate Erectile Dysfunction: Study Protocol for a Multi-Center, Randomized, Double-Blinded, Placebo-Controlled Clinical Trial.Int J Gen Med. 2023 Nov 24;16:5501-5513. doi: 10.2147/IJGM.S436347. eCollection 2023. Int J Gen Med. 2023. PMID: 38034900 Free PMC article.
References
-
- Aytaç IA, Araujo AB, Johannes CB, Kleinman KP, McKinlay JB. Socioeconomic factors and incidence of erectile dysfunction: findings of the longitudinal Massachussetts Male Aging Study. Soc Sci Med. 2000 Sep;51(5):771–778. - PubMed
-
- Prins J, Blanker MH, Bohnen AM, Thomas S, Bosch JLHR. Prevalence of erectile dysfunction: a systematic review of population-based studies. Int. J. Impot. Res. 2002 Dec;14(6):422–432. - PubMed
-
- Saigal CS, Wessells H, Pace J, Schonlau M, Wilt TJ. Predictors and prevalence of erectile dysfunction in a racially diverse population. Arch. Intern. Med. 2006 Jan 23;166(2):207–212. - PubMed
-
- Segraves RT, Knopf J, Camic P. Spontaneous remission in erectile impotence. Behav Res Ther. 1982;20(1):89–91. - PubMed
-
- Segraves RT, Camic P, Ivanoff J. Spontaneous remission in erectile dysfunction: a partial replication. Behav Res Ther. 1985;23(2):203–204. - PubMed
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous